NIH Licenses COVID-19 Research Tools and Early-Stage Technologies to WHO Program
WASHINGTON, D.C. — The U.S. National Institutes of Health (NIH) has recently licensed 11 COVID-19 research tools and early-stage vaccine and diagnostic candidates to the Medicines Patent Pool (MPP) through …
NIH Licenses COVID-19 Research Tools and Early-Stage Technologies to WHO Program Read More